The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.
about
Biology of double-hit B-cell lymphomasLoss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemiaMy treatment approach to patients with diffuse large B-cell lymphoma.Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.Pediatric B-cell lymphoma, unclassifiable, with intermediate features between those of diffuse large B-cell lymphoma and Burkitt lymphoma: a report of two cases.Aggressive B-cell lymphomas: how many categories do we need?The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.Grey zone lymphomas: lymphomas with intermediate features.Genetic lesions in diffuse large B-cell lymphomasClinicopathological Analysis of B Cell Lymphomas, Unclassifiable; with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma in a Tertiary Care Hospital in Southern IndiaB-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Burkitt's lymphoma: A case report and review.MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphomaClassification of AIDS-related lymphoma cases between 1987 and 2012 in Japan based on the WHO classification of lymphomas, fourth edition.Clinical significance of MYC expression and/or "high-grade" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative studyMolecular genetic characterization of lymphoma: application to cytology diagnosis.Emerging molecular networks in Burkitt's lymphoma.The impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma.Biomarkers in childhood non-Hodgkin's lymphomas.MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas.Biostable ssDNA aptamers specific for Hodgkin lymphomaSequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.Lentiviral vector-mediated siRNA knockdown of c-MYC: cell growth inhibition and cell cycle arrest at G2/M phase in Jijoye cells.Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma.Diagnosis and classification of hematologic malignancies on the basis of genetics.Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue.Diagnosing lymphoma in a setting with a high burden of infection: a pediatric case of Epstein-Barr virus-associated aggressive B-cell lymphoma with t(8;14) (q23;q32) and extensive necrosis mimicking tuberculosis.The t(14;18)(q32;q21) with extra MYC signal - is it a gray zone lymphoma?A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child.MYC Negative Rectal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in an Immunocompetent Patient.Investigation of potential traces of pluripotency in germinal-center-derived B-cell lymphomas driven by MYC.Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing.Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience.MYC addiction in chronic lymphocytic leukemia.MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection.Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.
P2860
Q26825581-EDDA0A6C-49B4-40FE-8980-A195B59B427CQ33648911-76605BD0-A2F7-4FDB-8EE8-01E9F5E2B3F8Q34251964-8B98277F-1981-40BF-92AF-BC7663FD8608Q34473466-AC9ABC78-96C5-45C4-9C1D-1321A992D602Q35030096-C8957276-8E57-4D79-A6A4-6FAC1DA38A91Q35084573-0A403136-1C8C-44E0-A2A8-1BC85A453C04Q35088498-43A90FF7-726B-4979-B9DD-8C8C367CA2E6Q35527893-C5D36476-16F9-4663-A9B8-7873EA837100Q35691157-5435D3F3-854D-444E-B9CE-97A4C12CF8C3Q35882774-0A251A41-9D76-4796-8897-EB1CA3BD3822Q35974341-36FE4C2D-E023-4B65-8B4C-6D828CBC7FA8Q36679590-A8EDC5A3-90D0-42AE-A8AA-329A6619B33BQ37185830-90034ADC-2543-46F8-98DB-7D620ACA8453Q37212700-3DCDBA1F-5207-41C2-B0FB-0488816B3795Q37569804-8143F069-33D6-4F76-B1AE-CB3D9561B501Q37595265-3234FC1F-AFBD-4D72-8F2B-330930DD105DQ37640313-67B7B678-90C4-4BCC-8C05-93CEFED66A15Q38012420-0B6EC76F-5C78-4564-9D2E-03359B208306Q38035787-CB945485-941C-451C-8793-EC332AEF14FFQ38124735-983247B6-CCC3-438F-AB54-7F6E516C8383Q38138608-450FDE71-744B-4581-B678-4ED129AAFC58Q38147318-DEA9D7FC-81DD-49F4-B2D5-E1E42658C8C9Q38311211-45BF3402-043F-4F9B-8F16-14E294BCC9DBQ38536238-63D83209-351C-4BE4-9FED-4515FE898299Q39154624-88138968-58A0-40B6-8F43-B789B962945CQ39220424-87EA08AA-9354-4AD3-8C4A-9D055A00EDAAQ39284024-0A94CF5B-F2C3-4308-A383-129128A80705Q39363409-B19EF13D-5692-41B2-8E03-4471EA906FE4Q40686927-75A96696-D9E2-480C-85EA-0B3760F7EB6BQ41346178-D117B381-E573-4EC9-97CD-5829D00750DBQ42024762-E6FB155F-4F72-4BA3-AC02-1F54770EB2DAQ42093345-35EEE275-BB0E-4E15-A34C-BEA9A41921FDQ42255144-70E2DB22-16CF-4861-A892-CAA555C5DDE4Q42413859-4F8EE2BE-AF69-4C5C-9A43-7046996BC3EFQ42550049-43642D32-F524-41E6-868C-8076E82F9CECQ43084886-3F6D80C7-43C4-4CF7-A64E-1E33724F220FQ44870266-8C20B78F-738D-434F-9B2C-2FC89DB8189CQ44879882-C8420064-5151-4619-B005-869CEF957C51Q46017773-634E4A5E-A678-4B24-BCBE-4A30A8CF1CE3Q46125111-EFD5F5D2-5992-4424-BDF8-B3469A9E9B06
P2860
The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The gray zone between Burkitt' ...... a from a genetics perspective.
@en
The gray zone between Burkitt' ...... a from a genetics perspective.
@nl
type
label
The gray zone between Burkitt' ...... a from a genetics perspective.
@en
The gray zone between Burkitt' ...... a from a genetics perspective.
@nl
prefLabel
The gray zone between Burkitt' ...... a from a genetics perspective.
@en
The gray zone between Burkitt' ...... a from a genetics perspective.
@nl
P356
P1476
The gray zone between Burkitt' ...... a from a genetics perspective.
@en
P2093
Itziar Salaverria
P304
P356
10.1200/JCO.2010.32.8385
P407
P577
2011-04-11T00:00:00Z